🔗 Share this article TikTok Influencers Driving Parallel Trade for Unlicensed Weight-Loss Drug A shadow economy for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations. Experimental Drug Gaining Traction Online Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these accounts directly for supplier links, while also obtaining promotional offers. Active Commerce on Messaging Platforms Separately, a robust market exists on messaging services, where communities with numerous of participants share comparison photos, administration instructions and assertions of rapid UK delivery. Sellers market the substance there before redirecting customers to other platforms for transactions. Understanding The Experimental Drug This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic. Healthcare Experts Voice Worries However, physicians and chemists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could lead to users administering products of uncertain source. Several professionals said the popularity for retatrutide could be linked to the rising cost of licensed slimming products such as Mounjaro. Legal Status and Enforcement Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the British medical regulations. Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate pharmaceutical, marketing, and customer laws, risking fines, prosecution or imprisonment. Service Reaction and Content Removal Based on TikTok, the service has removed violative material and banned associated keywords and query recommendations. The company said it was committed to keeping the platform secure and investing in strengthening compliance measures. Online Marketplace Activities Research also found communities with up to 9,000 members marketing the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays groups with numerous of members, filled with photos of slimming results, positive testimonials and step-by-step instructions for preparing or injecting at residence. After moments of entering one community, a vendor shared WhatsApp details, where most transactions take place. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about weight, health issues or past usage. Item Details and Pricing Within these groups, posts show black plastic packages with postal service labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.” Customers can select between powder vials, mixed at residence with sterile water, or pre-filled pens usually priced at £160 for 20mg. When questioned how much time a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”. Platform Oversight and Safety Measures A representative for Telegram stated it actively monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”. Medical Expert Cautions “Individuals are injecting materials they cannot confirm. Even if the research behind this drug is sound, these online products may not include what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service. A medical professional of an online medical service connected the increase in interest to current cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said. Her staff has previously encountered patients harmed by personal administration from unconfirmed sources. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.” Manufacturer Position A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company investigational substance not yet approved … may expose patients to possibly serious medical dangers”.